Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheldon Spector

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Lung|September 17, 2009
Use of mannitol inhalation challenge in assessment of coughSheldon Spector
Current Allergy and Asthma Reports|November 8, 2007
Pediatric sinusitisRicardo Tan, Sheldon Spector
Allergy and Asthma Proceedings|February 29, 2012
Exercise-induced bronchoconstriction update: therapeutic managementSheldon Spector, Ricardo Tan
Allergy and Asthma Proceedings|October 3, 2012
Omalizumab: an update on efficacy and safety in moderate-to-severe allergic asthmaBradley E Chipps, Maria Figliomeni, Sheldon Spector
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 3, 2010
Development of a daily diary for patients with chronic idiopathic urticariaSusan D Mathias, Stephen C Dreskin, Allen Kaplan, et al.
Respiratory Medicine|March 16, 2013
Dose-dependent anti-inflammatory effect of inhaled mometasone furoate/formoterol in subjects with asthmaHendrik Nolte, Ian Pavord, Vibeke Backer, et al.
Allergy and Asthma Proceedings|June 25, 2009
Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitisMichael A Kaliner, William Storms, Stephen Tilles, et al.
The Journal of Allergy and Clinical Immunology|July 19, 2011
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticariaSarbjit Saini, Karin E Rosen, Hsin-Ju Hsieh, et al.
Journal of Clinical Immunology|May 11, 2010
Efficacy and safety of a new 20% immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiencyJohn B Hagan, Mary B Fasano, Sheldon Spector, et al.
Clinical and Translational Allergy|August 20, 2016
Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studiesAna M Gimenéz-Arnau, Sheldon Spector, Evgeniya Antonova, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Lung|September 17, 2009
Use of mannitol inhalation challenge in assessment of coughSheldon Spector
Current Allergy and Asthma Reports|November 8, 2007
Pediatric sinusitisRicardo Tan, Sheldon Spector
Allergy and Asthma Proceedings|February 29, 2012
Exercise-induced bronchoconstriction update: therapeutic managementSheldon Spector, Ricardo Tan
Allergy and Asthma Proceedings|October 3, 2012
Omalizumab: an update on efficacy and safety in moderate-to-severe allergic asthmaBradley E Chipps, Maria Figliomeni, Sheldon Spector
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 3, 2010
Development of a daily diary for patients with chronic idiopathic urticariaSusan D Mathias, Stephen C Dreskin, Allen Kaplan, et al.
Respiratory Medicine|March 16, 2013
Dose-dependent anti-inflammatory effect of inhaled mometasone furoate/formoterol in subjects with asthmaHendrik Nolte, Ian Pavord, Vibeke Backer, et al.
Allergy and Asthma Proceedings|June 25, 2009
Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitisMichael A Kaliner, William Storms, Stephen Tilles, et al.
The Journal of Allergy and Clinical Immunology|July 19, 2011
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticariaSarbjit Saini, Karin E Rosen, Hsin-Ju Hsieh, et al.
Journal of Clinical Immunology|May 11, 2010
Efficacy and safety of a new 20% immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiencyJohn B Hagan, Mary B Fasano, Sheldon Spector, et al.
Clinical and Translational Allergy|August 20, 2016
Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studiesAna M Gimenéz-Arnau, Sheldon Spector, Evgeniya Antonova, et al.
Pageof 2